Status:
COMPLETED
Effect of Ovarian Stimulation With r-hLH/r-hFSH,r-hFSH and hMG in Reducing Apoptosis Rate in Cumulus Cells of Patients Undergoing ICSI
Lead Sponsor:
Centro di Biologia della Riproduzione, Palermo, Italy
Conditions:
Infertility
Eligibility:
FEMALE
30-45 years
Brief Summary
HP-hMG, recombinant FSH (r-hFSH) and a combination of r-hFSH/r-hLH, are commonly used for ovarian stimulation in infertile women undergoing IVF/ICSI treatments. Several publications have compared the ...
Detailed Description
HP-hMG, recombinant FSH (r-hFSH) and a combination of r-hFSH/r-hLH, are commonly used for ovarian stimulation in infertile women undergoing IVF/ICSI treatments. Several publications have compared the ...
Eligibility Criteria
Inclusion
- normal basal level of FSH (\< 12 IU/mL)
- normal body mass index (BMI = kg/m2 \< 28)
- poor or hyporesponse in a previous cycle according to Bologna criteria
Exclusion
- Azoospermia
- Endometriosis
- recurrent abortion
- recurrent failures after IVF
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT01872247
Start Date
January 1 2012
End Date
June 1 2013
Last Update
June 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Biologia della Riproduzione
Palermo, Italy, 90141